Introduction
Muhammad Shahzad Rauf*, Saad Akhtar, Irfan Maghfoor relative comparison against, Saudi cancer registry data (SCR 2009; 2010) , which is a population-based registry established in 1992, gulf countries data and IARC data. We also did brief retrospective analysis outcome of NHL presented to KFSH&RC and its comparison against international trials. All patients and / or their guardians provided informed consent for all treatments, procedures as per institutional requirements. The study conformed to the ethical guidelines of the World Medical Association Declaration of Helsinki. Kaplan-Meier method was used to do survival analysis.
Results
KFSH&RC is a tertiary care hospital for oncology and the foremost center for cancer therapy in KSA opened in June 1975. Tumor registry databases now include 75,233 malignant cases seen from . For each newly identified lymphoid neoplasm, patient information like, patient demographic data, including age and sex, and information on the tumor histologic type, primary site, type of treatment and immunophenotype were collected.
Based on trends in crude relative frequency, breast cancer led the list of total cancer cases seen followed by leukemia; NHL is 3 rd commonest cancer whereas HL is 8th commonest cancer seen at KFSH&RC in adult patients. (Figure 1 ).
NHL and HL
2008-2012: 1345 cases were diagnosed as Lymphoma, 790 diagnosed to have NHL with male to female ratio 1.3:1. In 2012, NHL account for 5.7% of all cancer cases. It is the 3rd commonest malignancy in male and 6th commonest in female adult. 555 patients were found to have HL with male to female ratio 1.4 to 1.Also in 2012 HL is the 11th commonest cancer in male and 7th commonest in female adults. In the U.S.A., it constitutes 0.6% of all cancers, compared to 3.8% of all cancers at KFSH&RC in 2012.
Age distribution
1975-2012: NHL patients registered, with peak incidence between 40-60 years of age whereas HL with peak incidence between 15-39 years as shown in (Ziepert et al., 2010) analyses from 1,062 patients treated with R-CHOP in three prospective clinical trials (MInT, 380 patients; DOI:http://dx.doi.org/10.7314/APJCP.2015.16.5 
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Mega CHOEP, 72 patients; RICOVER-60, 610 patients). 44 percent patients were advanced stage, 10% were found to be in high risk IPI category. 17% had more than one extra nodal involvement.
Treatment outcome
198 patients treated with R-CHOP from 2003-2007 at KFSH&RC. At a median follow-up for survivors of 68 months (19-102 months), event-free survivals (EFS) and overall (OS) were 55%, 64% respectively. EFS and OS for four groups according to IPI were 79%, 46%, 47%, 29% and 85%, 59%, 53%, 36% for low, low intermediate, high intermediate and high-risk groups respectively. In Ziepart et al analysis The IPI score was highly significant for the EFS, PFS, and OS end points, 3-year rate estimates for EFS, PFS, and OS: IPI 0 and 1: 81.3%, 87.0%, and 91.4%; IPI 2: 68.5%, 74.7%, and 80.9%; IPI 3: 53.2%, 58.6%, and 65.1%; IPI 4 and 5: 49.5%, 55.8%, and 59.0% respectively, when all 1,062 patients were analyzed as a single data. But 0nly 10 percent were found to be in high IPI category. 17% had more than one extra nodal involvement. Definition of bulky disease is variable so we could not do analyses.
Discussion
IARC estimated in 2012 that the worldwide agestandardized incidence rate (ASR) per 100,000 Population of NHL was 5.1, higher in men (ASR 6.0/100 000) then women (ASR 4.1/100 000). Israel with ASR of 16.2 found to have highest incidence of NHL. ASR in USA was 12.3. Incidence increased in many high-income countries between 1950s and 1990s, but no further increase has been observed during the past decade. Worldwide AgeStandardized mortality (ASM) was 2.5 per 100,000 populations. In the United States, ASM of NHL was found to be 3.5. World ASR of HL was 0.9. Again highest incidence found to be in Israel that is 3.7/100 000. Estimated ASR as per IARC 2012 of NHL in KSA is relatively higher than in some Gulf countries like United Arab Emirates, Bahrain and Kuwait. Despite the low ASR of NHL cancer in Saudi Arabia compared to western countries, the ASM of NHL remained slightly high. For example, the ASM of NHL in Australia, UK and USA were lower than KSA as shown in Table 2 In year 2009 and 2010, there were 680 cases of adult HL analyzed by SCR accounting for 3.5% of all newly diagnosed cases. It affected 388 (56%) males and 292 (44%) females. The overall ASR was 2/100,000 in 2009 and 1.9 in 2010. ASR was 2.3 in 2009 but was 2.1 in 2010 for males and 1.7 for females in both years. The median age at diagnosis was 25 years. 14% were diagnosed to have localized HL whereas 25% regional and 40% as distant disease. 21% were unknown stage. Based on SEER data from 2004-2010, 38% of patients diagnosed as distant disease.
Estimated ASR as per IARC 2012 of HL in KSA is relatively higher than in some Gulf countries like United Arab Emirates, Bahrain and Kuwait. Despite the low ASR of HL cancer in Saudi Arabia compared to western countries, the ASM of NHL remained slightly high. For example, the ASM of NHL in Australia, UK, USA and other Gulf countries were lower than KSA as shown in Table 3 .
In our study HL represents 41% of all lymphomas at KFSHRC which is lot higher than western countries which ranges between 5-15% whereas T cell lymphoma incidence is also relatively higher than western countries which ranges from 5-10% in western countries
In conclusion, our data clearly shows lymphoma remains one of the leading cancers in KSA and forms a significant proportion of new cancer patients referred to KFSH&RC. Crude relative frequencies of primary cancers seen at KFSH&RC are very different from the Western world. (Fatima et al., 2011) . Risk factors have been detected such as a higher consumption of carbohydrate in Oman (Ali et al., 2013) and cigarette smoking, consumption of mutton and consumption of milk in India. (Balasubramaniam et al., 2013) . These mentioned risk factors are different in various parts of the KSA and world resulting diverse distribution of lymphoid malignancy. Alarming feature is the ASM of lymphoma in KSA is higher as compare to few gulf countries. It is also evident that lymphoma patients presented at KFSH&RC are more advanced staged involving younger population and relatively have more extra nodal involvement, because of these bad prognostic features survival at KFSH&RC is lower as compare to survival data reported in various international studies.
Prevention of Lymphoma is vital subject among the KSA population. In this region, it has many epidemiologic and clinical features that are different from those in the rest of the world. Furthermore, relatively young population being involved with cancer and large discrepancies in the availability of resources at diagnostic and treatment levels. It is extremely important to have regional guidelines on cancer care, for lymphoid malignancies.
